These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10358938)

  • 1. Interaction of the recombinant herpes simplex virus type 1 thymidine kinase with thymidine and aciclovir: a kinetic study.
    Kussmann-Gerber S; Wurth C; Scapozza L; Pilger BD; Pliska V; Folkers G
    Nucleosides Nucleotides; 1999 Mar; 18(3):311-30. PubMed ID: 10358938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance of herpes simplex virus type 1--structural considerations at the molecular level of the thymidine kinase.
    Kussmann-Gerber S; Kuonen O; Folkers G; Pilger BD; Scapozza L
    Eur J Biochem; 1998 Jul; 255(2):472-81. PubMed ID: 9716390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Epstein-Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase.
    Gustafson EA; Chillemi AC; Sage DR; Fingeroth JD
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2923-31. PubMed ID: 9797227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mutations on herpes simplex virus 1 thymidine kinase functionality: an in vitro assay based on detection of monophosphate forms of acyclovir and thymidine using HPLC/DAD.
    Malartre N; Boulieu R; Falah N; Cortay JC; Lina B; Morfin F; Frobert E
    Antiviral Res; 2012 Sep; 95(3):224-8. PubMed ID: 22796575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity.
    Kokoris MS; Black ME
    Protein Sci; 2002 Sep; 11(9):2267-72. PubMed ID: 12192082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of C-terminus of herpes simplex virus type 1 thymidine kinase for maintaining thymidine kinase and acyclovir-phosphorylation activities.
    Saijo M; Suzutani T; Niikura M; Morikawa S; Kurane I
    J Med Virol; 2002 Mar; 66(3):388-93. PubMed ID: 11793392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The A167Y mutation converts the herpes simplex virus type 1 thymidine kinase into a guanosine analogue kinase.
    Balzarini J; Liekens S; Esnouf R; De Clercq E
    Biochemistry; 2002 May; 41(20):6517-24. PubMed ID: 12009916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active site.
    Maga G; Focher F; Wright GE; Capobianco M; Garbesi A; Bendiscioli A; Spadari S
    Biochem J; 1994 Aug; 302 ( Pt 1)(Pt 1):279-82. PubMed ID: 8068016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine.
    Prota A; Vogt J; Pilger B; Perozzo R; Wurth C; Marquez VE; Russ P; Schulz GE; Folkers G; Scapozza L
    Biochemistry; 2000 Aug; 39(31):9597-603. PubMed ID: 10924157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells.
    Schelling P; Claus MT; Johner R; Marquez VE; Schulz GE; Scapozza L
    J Biol Chem; 2004 Jul; 279(31):32832-8. PubMed ID: 15163659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the active site of herpes simplex virus type-1 thymidine kinase by X-ray crystallography of complexes with aciclovir and other ligands.
    Champness JN; Bennett MS; Wien F; Visse R; Summers WC; Herdewijn P; de Clerq E; Ostrowski T; Jarvest RL; Sanderson MR
    Proteins; 1998 Aug; 32(3):350-61. PubMed ID: 9715911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutagenesis of herpes simplex virus type 1 thymidine kinase opposes the importance of amino acid positions 251, 321 and 348 for selective recognition of substrate analogs.
    Michael M; Fetzer J; Folkers G
    Biochem Biophys Res Commun; 1995 Apr; 209(3):966-73. PubMed ID: 7733991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Focher F; Lossani A; Verri A; Spadari S; Maioli A; Gambino JJ; Wright GE; Eberle R; Black DH; Medveczky P; Medveczky M; Shugar D
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2028-34. PubMed ID: 17438061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the binding mode of N2-phenylguanine derivative inhibitors to herpes simplex virus type 1 thymidine kinase.
    Gaudio AC; Takahata Y; Richards WG
    J Comput Aided Mol Des; 1998 Jan; 12(1):15-25. PubMed ID: 9570086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and photoaffinity labeling of herpes simplex virus type-1 thymidine kinase.
    Rechtin TM; Black ME; Mao F; Lewis ML; Drake RR
    J Biol Chem; 1995 Mar; 270(13):7055-60. PubMed ID: 7706243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir.
    Bennett MS; Wien F; Champness JN; Batuwangala T; Rutherford T; Summers WC; Sun H; Wright G; Sanderson MR
    FEBS Lett; 1999 Jan; 443(2):121-5. PubMed ID: 9989588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rational of catalytic activity of herpes simplex virus thymidine kinase. a combined biochemical and quantum chemical study.
    Sulpizi M; Schelling P; Folkers G; Carloni P; Scapozza L
    J Biol Chem; 2001 Jun; 276(24):21692-7. PubMed ID: 11262392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding and self-assembly of herpes simplex virus type 1 thymidine kinase.
    Wurth C; Thomas RM; Folkers G; Scapozza L
    J Mol Biol; 2001 Oct; 313(3):657-70. PubMed ID: 11676546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.